Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study)
This is the prospective study to evaluate the efficacy of immunochemotherapy in patients with advanced or relapsed LCNEC. The results are expected to contribute to establishing the treatment strategy for LCNEC.
Authors
- Hidenobu Ishii
- Masataka Mori (ORCID: https://orcid.org/0000-0002-1473-8669)
- Kohei Yoshimine
- Fumiaki Kiyomi (ORCID: https://orcid.org/0000-0002-1001-3513)
- Masaru Takenaka (ORCID: https://orcid.org/0000-0002-4436-2850)
- Shunsuke Misono (ORCID: https://orcid.org/0000-0002-0700-1386)
- Eiji Iwama (ORCID: https://orcid.org/0000-0001-8252-290X)
- Koichi Azuma (ORCID: https://orcid.org/0000-0001-5040-5856)
- Hiroaki Kanemura (ORCID: https://orcid.org/0000-0002-0858-8107)
- Toshiyuki Sumi
- Takayasu Kurata
- Yuki Takeyasu (ORCID: https://orcid.org/0000-0003-3295-0273)
- Kazuki Uchida
- Tsutomu Iwasa (ORCID: https://orcid.org/0000-0001-5996-0602)
- Kazunori Tobino (ORCID: https://orcid.org/0000-0002-3456-6833)
- Tadaaki Yamada (ORCID: https://orcid.org/0000-0002-6945-281X)
- Kentaro Tanaka (ORCID: https://orcid.org/0000-0003-4602-4465)
- Isamu Okamoto
Institutions
- Kurume University (JP)
- Kagoshima University (JP)
- Kansai Medical University (JP)
- Kyushu University (JP)
- University of Occupational and Environmental Health Japan (JP)
- Kyoto Prefectural University of Medicine (JP)
- Kyushu Economic Research Center (JP)
- Aso Iizuka Hospital (JP)
- Hakodate National Hospital (JP)
- Kindai University (JP)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ctarc.2025.101008
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00